PRO-2000
N/A
Report date: 2022/07/04 19:38:02
NME
Base Information
Drug NamePRO-2000
Drug Alias Name
Classification
Mechanisms of Action
Targets
Therapy Area/Indications +[4]
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/Territory +[5]
CombinationsNo
Global Highest StatusDiscontinued (Phase 3 Clinical)
Highest Status in ChinaN/A
Originator CompaniesEndo International Plc
China Registration ClassN/A
Develop Information
Active CompaniesN/A
Inactive CompaniesNational Institute Of Allergy And Infectious Diseases (Niaid)Endo Pharmaceuticals Inc
Active IndicationsN/A
Inactive Indications +[4]